Advertisement
Person › Details
Thomas Kuhn (Poxel S.A. (Euronext: POXEL))
Kuhn, Thomas (Poxel 200904– CEO)
Organisation | Poxel S.A. (Euronext: POXEL) | |
Group | Poxel (Group) | |
Product | imeglimin | |
Record changed: 2021-05-18 |
Advertisement
More documents for Thomas Kuhn
- [1] Poxel S.A.. (5/25/20). "Press Release: Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases". Lyon....
- [2] Poxel S.A.. (5/25/20). "Press Release: Poxel Successfully Raises €17.7 Million in a Capital Increase [Not for US, AU, CA or JP]". Lyon....
- [3] Poxel S.A.. (11/5/19). "Press Release: Poxel Obtains Additional Funding to Advance Pipeline Programs. Financing of up to EUR 30 Million through a Bond Loan with IPF Partners". Lyon....
- [4] Poxel S.A.. (4/25/17). "Press Release: Poxel Announces Appointment of Anne Renevot as Chief Financial Officer". Lyon....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top